These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11889266)

  • 21. [Risk factors for the onset of Parkinson's disease].
    Icanović H; Stojanović M; Nikolić M
    Srp Arh Celok Lek; 1988 May; 116(5):413-7. PubMed ID: 3201340
    [No Abstract]   [Full Text] [Related]  

  • 22. Selegiline as neuroprotective therapy in Parkinson's disease: concepts and controversies.
    Langston JW
    Neurology; 1990 Oct; 40(10 Suppl 3):suppl 61-6; discussion 67-9. PubMed ID: 2120617
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical aspects of bowel symptoms in Parkinson's disease.
    Krogh K; Ostergaard K; Sabroe S; Laurberg S
    Acta Neurol Scand; 2008 Jan; 117(1):60-4. PubMed ID: 18095955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic Parkinson's disease: epidemiology, diagnosis and management.
    Ben-Shlomo Y; Sieradzan K
    Br J Gen Pract; 1995 May; 45(394):261-8. PubMed ID: 7619574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
    Naoi M; Maruyama W
    Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease.
    Bradford HF; Zhou J; Pliego-Rivero B; Stern GM; Jauniaux E
    Adv Neurol; 1999; 80():19-25. PubMed ID: 10410698
    [No Abstract]   [Full Text] [Related]  

  • 27. Maternal age is not a risk factor for Parkinson's disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Swerdlow RH; Manning CA; Wooten GF
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):130-1. PubMed ID: 11439965
    [No Abstract]   [Full Text] [Related]  

  • 28. Null hypothesis of husband-wife concordance of Parkinson's disease in 1,000 married couples over age 50 in Spain.
    Ubeda JV
    Neuroepidemiology; 1998; 17(2):90-5. PubMed ID: 9592785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mitochondrial dysfunction in Parkinson's disease: Implications for treatment.
    Ramsey CP; Giasson BI
    Drugs Aging; 2007; 24(2):95-105. PubMed ID: 17313198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of Parkinson's disease: risk factors and prevention.
    Ascherio A; Schwarzschild MA
    Lancet Neurol; 2016 Nov; 15(12):1257-1272. PubMed ID: 27751556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease.
    Kalia LV; Lang AE
    Lancet; 2015 Aug; 386(9996):896-912. PubMed ID: 25904081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease risk factors.
    Rajput AH; Uitti RJ
    Neurology; 1994 Aug; 44(8):1557-8. PubMed ID: 8058178
    [No Abstract]   [Full Text] [Related]  

  • 33. Current concepts on the etiology of Parkinson's disease.
    Calne DB
    Mov Disord; 1989; 4 Suppl 1():S11-4. PubMed ID: 2657406
    [No Abstract]   [Full Text] [Related]  

  • 34. Pesticides and Parkinson's disease.
    Le Couteur DG; McLean AJ; Taylor MC; Woodham BL; Board PG
    Biomed Pharmacother; 1999 Apr; 53(3):122-30. PubMed ID: 10349500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does levodopa aggravate Parkinson's disease?
    Blin J; Bonnet AM; Agid Y
    Neurology; 1988 Sep; 38(9):1410-6. PubMed ID: 3412589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Parkinson's disease following zolpidem use: a retrospective, population-based cohort study.
    Huang HC; Tsai CH; Muo CH; Lin KH; Lu MK; Sung FC; Kao CH
    J Clin Psychiatry; 2015 Jan; 76(1):e104-10. PubMed ID: 25650675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study.
    Huang HK; Wang JH; Lei WY; Chen CL; Chang CY; Liou LS
    Parkinsonism Relat Disord; 2018 Feb; 47():26-31. PubMed ID: 29174171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Ogawa N
    Acta Med Okayama; 2004 Oct; 58(5):221-33. PubMed ID: 15666991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the functional of neuromelanin.
    Smythies J
    Proc Biol Sci; 1996 Apr; 263(1369):487-9. PubMed ID: 8637929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monograph series on aging-related diseases: XII. Parkinson's disease--recent developments and new directions.
    Kontakos N; Stokes J
    Chronic Dis Can; 1999; 20(2):58-76. PubMed ID: 10455038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.